Proximod
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Proximod, covering 2026-01-13 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial. [Phase 2]